ATE223698T1 - Ophthalmische emulsionen mit verzoegerter freisetzung - Google Patents

Ophthalmische emulsionen mit verzoegerter freisetzung

Info

Publication number
ATE223698T1
ATE223698T1 AT96920588T AT96920588T ATE223698T1 AT E223698 T1 ATE223698 T1 AT E223698T1 AT 96920588 T AT96920588 T AT 96920588T AT 96920588 T AT96920588 T AT 96920588T AT E223698 T1 ATE223698 T1 AT E223698T1
Authority
AT
Austria
Prior art keywords
sustained release
emulsions
release ophthalmic
dispersed phase
ophthalmic emulsions
Prior art date
Application number
AT96920588T
Other languages
English (en)
Inventor
Lyle M Bowman
Rajesh A Patel
Thomas B Ottoboni
Original Assignee
Insite Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insite Vision Inc filed Critical Insite Vision Inc
Application granted granted Critical
Publication of ATE223698T1 publication Critical patent/ATE223698T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT96920588T 1995-06-07 1996-05-29 Ophthalmische emulsionen mit verzoegerter freisetzung ATE223698T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/488,675 US5767153A (en) 1995-06-07 1995-06-07 Sustained release emulsions
PCT/US1996/008119 WO1996040051A1 (en) 1995-06-07 1996-05-29 Sustained release ophthalmic emulsions

Publications (1)

Publication Number Publication Date
ATE223698T1 true ATE223698T1 (de) 2002-09-15

Family

ID=23940673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96920588T ATE223698T1 (de) 1995-06-07 1996-05-29 Ophthalmische emulsionen mit verzoegerter freisetzung

Country Status (7)

Country Link
US (2) US5767153A (de)
EP (1) EP0831775B1 (de)
AT (1) ATE223698T1 (de)
AU (1) AU5884996A (de)
DE (1) DE69623619D1 (de)
DK (1) DK0831775T3 (de)
WO (1) WO1996040051A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
AU9281698A (en) 1997-10-01 1999-04-23 Wakamoto Pharmaceutical Co., Ltd. O/w emulsion compositions
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US7141607B1 (en) * 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
ES2431640T3 (es) * 2003-08-21 2013-11-27 Sucampo Ag Composición oftálmica que comprende éster isopropílico de unoprostona y un agente de viscosidad
CN100484528C (zh) * 2003-11-07 2009-05-06 千寿制药株式会社 含有前列腺素的药物组合物
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
ES2314354T3 (es) * 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
US8586078B2 (en) * 2005-12-05 2013-11-19 Rba Pharma Inc. Emulsion-containing medical articles
US20080026013A1 (en) * 2006-07-28 2008-01-31 Laura Rabinovich-Guilatt Compositions containing quaternary ammonium compounds
US9132071B2 (en) * 2006-07-28 2015-09-15 Santen Sas Compositions containing quaternary ammonium compounds
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
US20080171790A1 (en) * 2007-01-12 2008-07-17 Filiberto Palmiro Zadini Fatty acids-systemic lipid solubilizers conjugates
ES2393814T3 (es) 2007-04-04 2012-12-28 Sigmoid Pharma Limited Una composición farmacéutica oral
EP2389939A1 (de) 2010-05-28 2011-11-30 Novagali Pharma S.A. Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen
US20110200645A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Free Fatty Acid Emulsions
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
EP0656779B1 (de) * 1992-08-28 2000-04-12 Pharmos Corporation Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery

Also Published As

Publication number Publication date
DK0831775T3 (da) 2002-10-07
DE69623619D1 (de) 2002-10-17
US5767153A (en) 1998-06-16
US5977171A (en) 1999-11-02
AU5884996A (en) 1996-12-30
WO1996040051A1 (en) 1996-12-19
EP0831775A1 (de) 1998-04-01
EP0831775B1 (de) 2002-09-11

Similar Documents

Publication Publication Date Title
ATE223698T1 (de) Ophthalmische emulsionen mit verzoegerter freisetzung
ATE192332T1 (de) Alkalische ophthalmische suspensionen
DE59608732D1 (de) Lagerstabile arzneiformen
BR9713414A (pt) Processo para a preparação de uma dispersão de polìmero.
DE69721489D1 (de) Herstellungsverfahren von löslichen verabreichungssystemen unter verwendung von flüchtigen salzen
DK0607118T3 (da) System til administrering af phospholipid
NO176696C (no) Fremgangsmåte for fremstilling av henholdsvis et medikamentavleveringssystem og et tåreerstatningssystem
PT809488E (pt) Preparacoes solidas de substancias activas****************
DK0744938T3 (da) Flydende oftalmisk afgivelsessystem med vedholdende afgivelse
PT1028707E (pt) Formulacoes oftalmicas de libertacao controlada contendo medicamentos soluveis em agua
FI843190A0 (fi) Tvaerbundna poroesa polymerer foer styrd laekemedelsfrigoerning.
ES8800849A1 (es) Metodo de floculacion.
DK0874642T3 (da) Lægemiddelformuleringer med forhalet frigørelse
ATE264348T1 (de) Bioadhesive zusammensetzungen aus polymeren
FI872490A0 (fi) Doseringsformer med foerdroejd frigivning.
EP0777451A4 (de) Ophthalmologisches abgabesystem
FI971172A0 (fi) Menetelmä annosyksikköjen valmistamiseksi märkärakeistamalla
SE442997B (sv) Forfarande utgorande av forfarandet enligt krav 1 i se,b, 432 770 varvid till den homogeniserade blandningen en oljeloslig polymerisationsinitiator tillsettes, vilken har en vattenloslighet som medger att den kan diffun
NO950595D0 (no) Oftalmologisk preparat
ES523586A0 (es) "metodo de preparacion de una composicion contraceptiva para administracion vaginal"
NZ331051A (en) Instant release forms of gelled active substances
ATE194489T1 (de) Bioerodierbares system zur kontrollierten freigabe
Tulunay et al. The effects of morphine and Δ-9-tetrahydrocannabinol on motor activity in rats
EP0480391A3 (en) Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions
ATE206040T1 (de) Sulfatierte polyvinylalkoholpolymere zur stabilisierung von arzneimitteln

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties